Title of article :
Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)
Author/Authors :
Limpijankit، نويسنده , , Thosaphol and Mehran، نويسنده , , Roxana and Mintz، نويسنده , , Gary S. and Dangas، نويسنده , , George and Lansky، نويسنده , , Alexandra J. and Kao، نويسنده , , John and Ashby، نويسنده , , Dale T. and Moussa، نويسنده , , Issam and Stone، نويسنده , , Gregg W. and Moses، نويسنده , , Jeffrey W. and Leon، نويسنده , , Martin B. and Teirstein، نويسنده , , Paul S.، نويسنده ,
Abstract :
We report the long-term outcome of 225 patients who failed γ-brachytherapy for in-stent restenosis. Total adverse events, target vessel revascularization, and myocardial infarction were higher after repeat percutaneous coronary intervention versus coronary artery bypass grafting. Therefore, coronary artery bypass grafting may be the preferable first-line therapy in these patients until other therapies (i.e., drug-eluting stents) are available. Shorter time from brachytherapy to radiation failure and late thrombosis after brachytherapy were independent predictors of adverse events.
